Altered endothelin-1 binding following balloon angioplasty of pig coronary arteries: Effect of the ET(A) receptor antagonist, LU 135252

Cardiovascular Research

Volumn 43, Issue 2, 1999, Pages 445-456

  Dashwood, Michael R ^a   Noertersheuser, Peter ^b   Kirchengast, Michael ^b   Münter, Klaus ^b  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b Knoll AG   (Germany)

Author keywords

Coronary arteries; Endothelin receptors; Experimental; Histology; Pharmacology angioplasty; Restenosis; Vasculature

Indexed keywords

DARUSENTAN; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY; CORONARY SINUS; IMMUNOREACTIVITY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LOCALIZATION; RESTENOSIS; SWINE; VASCULAR ENDOTHELIUM;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANIMALS; AUTORADIOGRAPHY; CORONARY DISEASE; CORONARY VESSELS; ENDOTHELIN-1; IMMUNOHISTOCHEMISTRY; PHENYLPROPIONATES; PROTEIN BINDING; PYRIMIDINES; RANDOM ALLOCATION; RECEPTORS, ENDOTHELIN; RECURRENCE; SWINE;

EID: 0033179175     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00097-8     Document Type: Article

References (34)

1. Yanagisawa M., Kurihara H., Kimura S., et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 332:1988;411-415.
2. Rubanyi G.M., Polokoff M.A. Endothelins: Molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev. 46:1994;325-415.
3. Tahara A., Kohno M., Yanagi S., et al. Circulating immunoreactive endothelin in patients undergoing percutaneous transluminal coronary angioplasty. Metabolism. 40:1991;1235-1237.
4. Trachtenberg J.D., Sun S., Choi E.T., Callow A.D., Ryan U.S. Effect of endothelin-1 infusion on the development of intimal hyperplasia after balloon catheter injury. J Cardiovasc Pharmacol. 22:1993;S355-S359.
5. Douglas S.A., Louden C., Vickery-Clark L.M., et al. A role for endogenous endothelin-1 in neointimal formation after rat carotid artery balloon angioplasty. Circ Res. 75:1994;190-197.
6. Douglas S.A., Vickery-Clark L.M., Louden C., Ohlstein E.H. Selective ETA receptor antagonism with BQ-123 is insufficient to inhibit angioplasty induced neointima formation in the rat. Cardiovasc Res. 29:1995;641-646.
7. A-receptor antagonist inhibits neointima formation induced by endothelial injury. Pharm Pharmacol Lett. 6:1996;90-92.
8. 125I]-Endothelin-1 binding to vasa vasorum and regions of neovascularization in human and porcine blood vessels: a possible role for endothelin in intimal hyperplasia and atherosclerosis. J Cardiovasc Pharmacol. 22:1993;S343-S347.
9. 125I]-PD 151242: a possible selective radioligand for human ETA receptors. Br J Pharmacol. 111:1992;4-6.
10. B binding sites in human coronary vasculature. J Cardiovasc Pharmacol. 26:1995;S351-S354.
11. 1,3,11,15]-ET-1 in human heart. Br J Pharmacol. 107:1992;637-639.
12. Moody C.J., Dashwood M.R., Sykes R.M., et al. Functional and autoradiographic evidence for endothelin 1 receptors on human and rat cardiac myocytes: comparison with single smooth muscle cells. Circ Res. 67:1990;764-769.
13. Ong A., Jowett T.P., Firth J.D., et al. An endothelin-1 mediated autocrine growth loop involved in human renal tubular regeneration. Kidney Int. 48:1995;390-401.
14. Timm M., Kaski J.C., Dashwood M.R. Endothelin-like immunoreactivity in atherosclerotic human coronary arteries. J Cardiovasc Pharmacol. 26:1995;S442-S444.
15. Chua B.H.L., Krebs C.J., Chua C.C., Diglio C.A. Endothelin stimulates protein synthesis in smooth muscle cells. Am J Physiol. 262:1992;E412-E416.
16. Kanse S.M., Takahashi K., Warren J.B., et al. Production of endothelin by vascular smooth muscle cells. J Cardiovasc Pharmacol. 17:1991;S113-S116.
17. Kanse S.M., Wijelath E., Kanthou C., Newman P., Kakkar V.V. The proliferative responsiveness of human vascular smooth muscle cells to endothelin correlates with endothelin receptor density. Lab Invest. 72:1995;76-82.
18. Zeiher A.M., Ihling C., Pistorius K., Schachinger V., Schäfer H.-E. Increased tissue endothelin immunreactivity in atherosclerotic lesions associated with acute coronary syndrome. Lancet. 344:1994;1405-1406.
19. Lerman A., Edwards B.S., Hallet J.W., et al. Circulating and tissue endothelin immunreactivity in advanced atherosclerosis. N Engl J Med. 325:1991;997-1001.
20. Wang X., Douglas S.A., Louden C., et al. Expression of endothelin-1, endothelin-3, endothelin-converting-enzyme-1, and endothelin-A and endothelin-B receptor mRNA after angioplasty-induced neointimal formation in the rat. Circ Res. 78:1996;322-328.
21. Hata H., Ohara Y., Kuga T., et al. Vasoreactivity and restenosis after coronary angioplasty in the atherosclerotic pig model. Coron Art Dis. 6:1995;503-511.
22. Shi Y., O'Brien J.E., Fard A., et al. Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation. 94:1996;1655-1664.
23. Schwartz R.S., Edwards W.D., Bailey K.R., et al. Differential neointimal response to coronary artery injury in pigs and dogs. Arterioscler Thromb. 14:1994;395-400.
24. Kirchengast M., Münter K. Endothelin and restenosis. Cardiovasc Res. 39:1998;550-555.
25. B) and immunoreactive ET-1 in porcine saphenous vein-carotid artery interposition grafts. Atherosclerosis. 137:1998;242.
26. Dashwood M.R., Angelini G.D., Mehta D., et al. Effect of angioplasty and grafting on porcine vascular nerves: A potential neurotropic role for endothelin-1. J Anat. 192:1998;435-437.
27. B receptor antagonism using BQ-123 and SB 209670. J Cardiovasc Pharmacol. 26:1995;186-189.
28. Kowala M.C. The role of endothelin in the pathogenesis of atherosclerosis. August T.J., Anders M.W., Murad F., Coyle J.T. Advances in pharmacology. 1997;299-318 Academic Press, San Diego.
29. Ohlstein E.H., Douglas S.A. Endothelin and the pathogenesis of restenosis. Feuerstein G.Z. Coronary restenosis: from genetics to therapeutics. 1997;129-142 Marcel Dekker, New York.
30. B receptor antagonist blocks proliferation of rat vascular smooth muscle cells after balloon angioplasty. Life Sci. 56:1995;PL449-PL454.
31. B receptor antagonists inhibit balloon catheter-induced smooth muscle cell proliferation in the rat thoracic aorta [abstract]. Br J Pharmacol. 114:1995;199P.
32. Wessale J.L., Adler A.L., Novosad E.I., et al. Endothelin antagonism reduces neointima formation following balloon angioplasty in rabbit [abstract]. Endothelin. 4:1995;153.
33. B receptors in the hyperplastic vascular wall. J Cardiovasc Pharmacol. 25:1995;802-809.
34. A receptor antagonism reduces neointimal hyperplasia in a porcine coronary stent model. Circulation. 97:1998;2551-2556.